Pfizer's sales missed estimates for the quarter as the drugmaker tries to transition out of the pandemic. Pfizer chairman and CEO Albert Bourla discusses the path ahead for the company, including its plans for acquisitions. He speaks with Bloomberg Wall Street Week host David Westin.

Former SEC Chair Gary Gensler Talks SpaceX & Mega IPO Risks
09:04

Jim Chanos Talks SpaceX IPO
13:48

US Energy Secretary Chris Wright Talks Oil Flows Through Strait of Hormuz
26:52